Methylfolate as Monotherapy in Depression. A Pilot Randomised Controlled Trial
Journal Title: Journal of Neurology and Psychology - Year 2015, Vol 3, Issue 1
Abstract
Background: The commonest neuropsychiatric complication of severe folate deficiency is depression. Placebo controlled trials of folates as adjunctive therapy in major depression have confirmed that they enhance the response to standard antidepressant medication, even in the absence of folate deficiency. We have undertaken a pilot randomised controlled trial of 5-methyltetrahydrofolate (5- MTHF) monotherapy against Amitriptyline in out-patients with mild to moderate depression. Methods: 31 patients, aged 20 – 69 years with DSM-111-R criteria for a depressive episode of mild to moderate severity and a Montgomery Asberg Depression Score (MADS) of at least 14 were randomly allocated to 5-MTHF 50 mgs (25 mgs biologically active) or Amitriptyline 150 mgs for 6 weeks. Clinical response was defined as a fall in MADS of 25% or more. Non-responders to initial therapy were crossed over to the alternative active therapy for a further six weeks. Haemoglobin, mean cell volume, serum and red cell folate and serum vitamin B12 were measured at entry to the study, after six weeks of initial and crossover treatment and at six months. Results: Of 19 patients randomised (n = 16) or crossed over (n = 3) to treatment with 5-MTHF for six weeks, eight (42%) responded. Of 20 patients randomised (n = 15) or crossed over (n = 5) to Amitriptyline, seven (35%) responded. Only 3 patients (10%) had low or borderline red cell folate values at randomisation. Response to 5-MTHF was associated with a significantly greater rise in red cell folate. Conclusions: Placebo controlled trials of 5-MTHF as monotherapy in depression would be justifiable. Our observations together with studies of S-adenosylmethionine (SAM) and nitrous oxide (N2O) are consistent with the hypothesis that 5-MTHF has intrinsic mood elevating properties in some patients.
Authors and Affiliations
Edward H Reynolds
Keywords
Related Articles
- EP ID EP197342
- DOI 10.13188/2332-3469.1000019
- Views 149
- Downloads 0
Moving Fingers Moving Toes: A Heterogeneous Entity
Painful legs and moving toes is a rare movement disorder. It can be associated with peripheral neuropathy, trauma, radiculopathy or autonomic disturbances. Variants of the phenomenon involving fingers and arms, with or w...
Auditory Information Processing During Meditation Based on Evoked Potential Studies
Background: Auditory evoked potentials (AEPs) were recorded to examine the neurophysiological correlates of four mental states described in ancient yoga texts. These are (i) focused attention (dharana), (ii) contemplatio...
What is the function of the Brain? What does it do and how does it do it? It functions as a Neuroregulator, which continuously regulates the Autonomic Nervous System and Physiological Systems, and enables us to Recognise that Sleep Exhibits the Characteristics of a Neurally Regulated Physiological System
The aim of this article is to provoke further discussion of the mechanisms which the brain uses to regulate the body´s function, in particular the autonomic nervous system. It focuses upon an understanding of the structu...
Moyamoya Disease: A Rare Sickle Cell Trait Neurological Complication
ntroduction: Sickle cell disease is an inherited blood disorder with multisystem complications, including cerebrovascular accidents primarily due to micro infarcts. However, people with sickle cell trait, the heterozygou...
Rumination: Deductions on Inductions
Rumination is a well established cognitive vulnerability to depressed mood. Research exploring the causal relationship between rumination and depressed mood has used an induction method limited by its design and the defi...